NCT02536417View on ClinicalTrials.gov

Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 29, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Delirium
Interventions
DRUG

Melatonin

To determine the effectiveness of melatonin in preventing the development of delirium compared with placebo

DRUG

Sugar pill

To determine if placebo effect plays a part in preventing the development of delirium

Trial Locations (1)

V3V 1Z2

Surrey Memorial Hospital, Surrey

Sponsors

Lead Sponsor

Fraser Health
All Listed Sponsors
lead

Fraser Health

OTHER